...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: No mention of efficacy again...
1
Mar 27, 2019 01:04PM

Bear there was a planned futility analysis for "aducanumab".

This explains it.

https://www.ctvnews.ca/health/neurologist-optimistic-about-alzheimer-s-treatment-despite-halted-trials-1.4354310

Koo

6
Mar 29, 2019 01:05PM
2
Mar 29, 2019 02:01PM
4
Mar 29, 2019 07:25PM
2
Mar 29, 2019 07:59PM
4
bfw
Mar 29, 2019 09:04PM
2
Mar 29, 2019 09:07PM
2
Mar 29, 2019 09:27PM
Share
New Message
Please login to post a reply